Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02438813 · ClinicalTrials.gov registry record
Condition of Submental Fullness and Treatment Outcomes Registry
A clinical trial, sponsored by Kythera Biopharmaceuticals.
- Completed
- Registry status
- 1,029
- Enrollment target
NCT02438813: Completed study, sponsored by Kythera Biopharmaceuticals.
NCT02438813 is a clinical trial that has completed, run by Kythera Biopharmaceuticals. The registered enrollment target is 1,029 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02438813 has completed, sponsored by Kythera Biopharmaceuticals.
- COMPLETED
- Registry status
- 1,029 participants
- Enrollment target
Study Summary
The primary objective of this registry is to develop a comprehensive understanding of the condition of submental (SM) fullness due to submental fat (SMF), how it is treated in current clinical practice, and the risks and benefits associated with its treatment.
Primary Outcome
An adverse event is any undesirable medical occurrence or worsening of an existing condition that occurs after SMF reduction treatment, irrespective of whether the event is considered treatment related. A treatment-emergent adverse event is defined as an adverse event with an onset that occurs after receiving treatment.
Interventions
- DRUG Deoxycholic acid
- PROCEDURE Surgical Procedures
- PROCEDURE Laser Liposuction
- DEVICE Energy Devices
- OTHER Other Treatments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,029 participants |
| Start Date | 2015-05-11 |
| Est. Completion | 2016-11-10 |
What the finished NCT02438813 record still lists
NCT02438813 is an observational study that tracks outcomes without assigning an intervention. Its 1,029 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 5 interventions - of which Deoxycholic acid is the first listed.
NCT02438813 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02438813 about?
NCT02438813 is a clinical study titled "Condition of Submental Fullness and Treatment Outcomes Registry". The primary objective of this registry is to develop a comprehensive understanding of the condition of submental (SM) fullness due to submental fat (SMF), how it is treated in current clinical practice, and the risks and benefits associated with its treatment.
What is the current status of trial NCT02438813?
This trial is currently completed. The enrollment target is 1,029 participants. The study started on 2015-05-11. Estimated completion is 2016-11-10.
What interventions are being tested in trial NCT02438813?
The interventions under investigation include: Deoxycholic acid (DRUG), Surgical Procedures (PROCEDURE), Laser Liposuction (PROCEDURE), Energy Devices (DEVICE), Other Treatments (OTHER).
Who is sponsoring clinical trial NCT02438813?
This trial is sponsored by Kythera Biopharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06080698 · 1,030 participants · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
- NCT07084363 · 1,032 participants · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
- NCT02200276 · 1,025 participants · NA
Influenza Immunization in Adults Over Age 75
- NCT02296450 · 1,025 participants
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI